This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The University of Tokushima. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Tsunetomo Takei: Innovator in Mucosal Vaccine Technology
Introduction
Tsunetomo Takei is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of immunology, particularly in the development of mucosal vaccines. His innovative work focuses on utilizing synthetic peptides to enhance vaccine efficacy.
Latest Patents
Tsunetomo Takei holds a patent for an "Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same." This invention presents a novel antigen-and-drug (AD) vehicle capable of inducing the production of secretory IgA antibodies. The AD vehicle is a complex of a synthetic peptide with specific amino acid sequences and lipids. The mucosal vaccine is designed to induce mucosal immunity by allowing an antigen to interact with the AD vehicle.
Career Highlights
Takei is affiliated with The University of Tokushima, where he conducts research and develops innovative solutions in vaccine technology. His work has garnered attention for its potential to improve immunization strategies.
Collaborations
Some of his notable coworkers include Hiroshi Kido and Dai Mizuno, who contribute to the research efforts at The University of Tokushima.
Conclusion
Tsunetomo Takei's contributions to mucosal vaccine technology highlight the importance of innovation in the field of immunology. His work continues to pave the way for advancements in vaccine development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile